| Ellisa Long Baker, OTR/L | |
|
4900 University Sq Ste 24, Huntsville, AL 35816-1829 | |
| (256) 387-7415 | |
| Not Available |
| Full Name | Ellisa Long Baker |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 4900 University Sq Ste 24, Huntsville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114542206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 5202 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellisa Long Baker, OTR/L 251 Boles Rd, Hazel Green, AL 35750-8429 Ph: (256) 585-4786 | Ellisa Long Baker, OTR/L 4900 University Sq Ste 24, Huntsville, AL 35816-1829 Ph: (256) 387-7415 |
News Archive
Disruption of two genes that control circadian rhythms can lead to diabetes, a researcher at UT Southwestern Medical Center has found in an animal study. Mice with defective copies of the genes, called CLOCK and BMAL1, develop abnormalities in pancreatic cells that eventually render the cells unable to release sufficient amounts of insulin.
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding episodes by 87%.
› Verified 6 days ago
Pamela L Cook, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2061 Poole Drive, Huntsville, AL 35810 Phone: 256-424-6500 | |
Kaitlin Terry, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 927 Franklin St Se, 2nd Floor, Huntsville, AL 35801 Phone: 256-428-3000 Fax: 256-428-3003 | |
Lisa Holloway, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2701 Meridian St N, Huntsville, AL 35811 Phone: 256-852-5170 | |
Jennifer Deanna Hembree, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3313 Memorial Pkwy Sw Ste 122, Huntsville, AL 35801 Phone: 256-883-7338 | |
Joelle Walden, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1622 Pratt Ave Ne, Huntsville, AL 35801 Phone: 217-417-5325 | |
Emma Kaye Grantham, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4769 Whitesburg Dr Se Ste 202, Huntsville, AL 35802 Phone: 256-666-0477 Fax: 256-666-0465 | |
Mrs. Gena Patrick Hornsby, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2075 Max Luther Dr, Huntsville, AL 35810 Phone: 256-852-5600 Fax: 256-852-6722 |